Search results - 155 results
Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
Papillomavirus Infections Pilot Projects Point-of-Care Systems Uterine Cervical Neoplasms Abstract: BACKGROUND: Globally, cervical cancer is a major public health problem, with about 604,000 new cases and over ...
Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management.
Female Humans Meta-Analysis as Topic Papillomavirus Infections Sensitivity and Specificity Systematic Reviews as Topic Uterine Cervical Dysplasia Uterine Cervical Neoplasms Abstract: INTRODUCTION: Human ...
ESGO Prevention Committee opinion: is a single dose of HPV vaccine good enough?
Uterine Cervical Neoplasms Abstract: Download the extract or click on the link to access the full publication. Service: Centre du cancer Kankercentrum Cancer centre Manuscript versions: DOI: ...
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
Cervical Dysplasia Uterine Cervical Neoplasms Abstract: AIM: The Papilloplex high-risk human papillomavirus (hrHPV) test (Genefirst, Oxford, UK) is a single tube real-time HPV test which provides multiplex ...
HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions.
Uterine Cervical Neoplasms Abstract: In 2017, cervical cancer screening in the Netherlands switched from cytology to human papillomavirus (HPV) testing using the validated PCR-based cobas 4800. Women could ...
IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues.
POLICY Quality Control Uterine Cervical Neoplasms Abstract: We advise that only clinically validated HPV assays which have fulfilled internationally accepted performance criteria be used for primary ...
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.
Partha; Bray, Freddie; Vaccarella, Salvatore Source: Lancet Glob Health, Volume 11, Issue 2 (2023) Keywords: Female Global Health Humans incidence Malawi Uganda Uterine Cervical Neoplasms World Health ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
Infections Real-Time Polymerase Chain Reaction Reproducibility of Results Sensitivity and Specificity Uterine Cervical Dysplasia Uterine Cervical Neoplasms Abstract: Human papillomavirus (HPV) assays used in ...
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.
J De Grève Source: ESMO Open, Volume 7, Issue 4 (2022) Keywords: Belgium Genomics Humans Medical Oncology Neoplasms Precision Medicine Abstract: PRECISION is an initiative from the Belgian Society of ...
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
Volume 13 (2022) Keywords: BNT162 Vaccine COVID-19 Cytokines Female Humans Intercellular Signaling Peptides and Proteins Neoplasms Placenta Growth Factor vaccines Abstract: BACKGROUND: Patients with ...